Glaxo and Genmab drop IV version of MS immune drug
Glaxo and Genmab drop IV version of MS immune drug
GlaxoSmithKline PLC and Genmab A/S will end the development of an intravenous form of a drug intended to treat autoimmune diseases like lupus and multiple sclerosis, and focus on an injectable version.
The companies said an injectable version of Arzerra (ofatumumab) should be more convenient for patients and have fewer side effects. The drug can also be used to treat rheumatoid arthritis...Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1397
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 1 Replies
- 1952 Views
-
Last post by goellerc
-
- 0 Replies
- 1187 Views
-
Last post by ElliotB
-
- 3 Replies
- 5043 Views
-
Last post by NHE
-
- 5 Replies
- 15649 Views
-
Last post by gibbledygook
-
- 1 Replies
- 1594 Views
-
Last post by ElliotB
-
- 0 Replies
- 1211 Views
-
Last post by DIM
-
- 0 Replies
- 610 Views
-
Last post by NHE
-
- 0 Replies
- 1711 Views
-
Last post by NHE
-
- 1 Replies
- 3313 Views
-
Last post by Tif